Keywords: prostatic neoplasms; biomarkers; tumor; kallikreins; African Americans; neoplasm grading; AA; African American; DRE; digital rectal examination; GG; Grade Group; PSA; prostate specific antigen;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: DRE; Drug-resistant epilepsy; ILAE; International League Against Epilepsy; IQ; Intelligence quotient; QOL; Quality of life; SD; Standard deviation; WHO; World Health Organisation; Epilepsy; Neurological rehabilitation; Social stigma; Surgery;
Keywords: PCa; prostate cancer; PSA; prostate specific antigen; DRE; digital rectal examination; PSAD; prostate specific antigen density; BPH; benign prostatic hyperplasia; AUC; area under curve; KATH; Komfo Anokye Teaching Hospital; ROC; receiver operating charact
Keywords: prostatic neoplasms; mass screening; mortality; failure to rescue; health care; early detection of cancer; DRE; digital rectal examination; ERSPC; European Randomized study of Screening for Prostate Cancer; PSA; prostate specific antigen; TRUS; transrecta
Keywords: DRE; drug resistant epilepsy; Cohort studies; Antiepileptic drugs; Epilepsy surgery; Hippocampal sclerosis;
Keywords: prostatic neoplasms; prostatectomy; elasticity imaging techniques; diagnostic imaging; pathology; DRE; digital rectal examination; GS; Gleason score; LRP; laparoscopic radical prostatectomy; MRI; magnetic resonance imaging; PCa; prostate cancer; PSA; pros
Keywords: ARSIs; androgen receptor signaling inhibitors; AA; abiraterone acetate; AR; androgen receptor; BPH; benign prostatic hyperplasia; CNV; copy number variation; CRPC; castration resistant prostate cancer; CTC; circulating tumor cells; ctDNA; cell-free circul
Keywords: Emergency shutdowns of chemical plants; Ozone pollution; DRE; Air-quality modeling;
Keywords: ADT; androgen deprivation therapy; PSA; prostate specific antigen; DRE; digital rectal examination; Skin metastasis; Prostate cancer; Africa;
Keywords: DRE; drug resistant epilepsy; PWE; patients with epilepsies; AEDs; anti-epileptic drugs; MTLE; mesial temporal lobe epilepsy; FCD; focal cortical dysplasia; BCRP; breast cancer resistance protein; MVP; major vault protein; MDT; smultidrug transporters; BB
Keywords: abdominal radiograph; KUB; constipation management; DRE; Digital rectal examination;
Keywords: CM; cavernous malformation; CRE; CM-related epilepsy; AED; antiepileptic drug; 1-YTR; terminal 1 year remission; YR; year seizure remission; SFR; seizure-free rate; MRI; magnetic resonance image; ILAE; International League Against Epilepsy; DRE; drug resi
Keywords: prostatic neoplasms; prostatectomy; biopsy; outcome and process assessment (health care); prostate specific antigen; AS; active surveillance; BCR; biochemical recurrence; Bx; biopsy; DRE; digital rectal examination; LN; lymph node; PCa; prostate cancer; P
Keywords: AMI; acute mesenteric ischemia; AVM; arteriovenous malformation; BRBPR; bright red blood per rectum; CI; colon ischemia; CT; computed tomography; DRE; digital rectal examination; EGD; esophagogastroduodenoscopy; GI; gastrointestinal; IBD; inflammatory bow
Keywords: TLE; temporal lobe epilepsy; SE; status epilepticus; DRE; drug-resistant epilsepy; KA; kainic acid; pd; post-natal days; Epilepsy models; Behavioral tests; Emotional factors; Cognition; Social impairments;
Keywords: PCa; prostate cancer; PSA; prostate screening antigen; DRE; digital rectal examination; NDVI; normalized difference vegetation index; CI; confidence interval; Prostate cancer; Greenness; Case-control study; GIS; Environment;
Keywords: BA; benzyl acrylate; DE; dose effect; DMA; dynamic mechanical analysis; DMPA; 2,2-dimethoxy-2-phenylacetophenone; DRE; dose rate effects; EB; electron beam; HPOPA; 2-hydroxy-3-phenoxypropyl acrylate; PA; phenyl acrylate; PEA; 2-phenylethyl acrylate; PET;
Keywords: DRE; digital rectal examination; PSA; prostate-specific antigen; USPSTF; U.S. Preventative Services Task Force;
Keywords: prostatic neoplasms; biomarkers; early detection of cancer; prognosis; DRE; digital rectal examination; FDA; Food and Drug Administration; mpMRI; multiparametric MRI; MRI; magnetic resonance imaging; NCCN®; National Comprehensive Cancer Network®; PCA3;
Keywords: prostatic neoplasms; biopsy; diagnosis; mortality; risk; ACM; all-cause mortality; DRE; digital rectal examination; PCa; prostate cancer; PCSM; prostate cancer specific mortality; PSA; prostate specific antigen; TRUS; transrectal ultrasound;
Keywords: prostatic neoplasms; magnetic resonance imaging; image-guided biopsy; diagnostic imaging; risk; CS; clinically significant; DRE; digital rectal examination; FBx; MRI/TRUS fusion-guided biopsy; mpMRI; multiparametric MRI; MRI; magnetic resonance imaging; P
Keywords: CCE; colon capsule endoscopy; CI; confidence interval; CRC; colorectal cancer; DRE; digital rectal examination; FDA; Food and Drug Administration; FIT; fecal immunochemical test; FS; flexible sigmoidoscopy; gFOBT; guaiac-based fecal occult blood test; GRA
Keywords: prostatic neoplasms; prostatic intraepithelial neoplasia; biopsy; quality improvement; diagnosis; ASAP; atypical small acinar proliferation; BCBSM; Blue Cross Blue Shield of Michigan; DRE; digital rectal examination; HGPIN; high grade prostatic intraepith
Keywords: prostatic neoplasms; prostate-specific antigen; watchful waiting; African continental ancestry group; Caribbean region; AS; active surveillance; BCR; biochemical recurrence; CAPRA-S; Cancer of the Prostate Risk Assessment Postsurgical; DRE; digital rectal
Keywords: biopsy; China; early detection of cancer; prostatic neoplasms; prostate-specific antigen; DRE; digital rectal examination; Durham VA; Durham Veteran Affairs Hospital; ERSPC; European Randomized Study of Screening for Prostate Cancer; HGPCa; high grade pro
Keywords: CAC; Ottawa Regional Prostate Cancer Assessment Center; DRE; digital rectal examination; PSA; prostate-specific antigen; RR; relative risk;
Keywords: PCa; prostate cancer; PSA; prostate screening antigen; DRE; digital rectal exam; OR; odds ratio; CI; confidence interval; Prostate cancer; Alcohol; Etiology; Case-control;
Keywords: Pca; prostate cancer; mpMRI; multiparametric magnetic resonance imaging; EBRT; external beam radiation therapy; DRE; digital rectal examination; TRUS; transrectal ultrasonography; PSA; prostate-specific antigen; GS; Gleason score; NCCN; National comprehen
Keywords: DRE; drug-resistant epilepsy; ROCF; Rey-Osterrieth Complex Figure; TMT-A; Trail Making Test-A; ILAE; International League Against Epilepsy; FGB; foreign-born group; ICG; Italian control group; EZ; epileptogenic zone; YI; years in Italy; VIF; variance infl
Keywords: EEG; Encephalitis; NMDAR; Herpes; FIRES; DRE; Autoimmune; ADEM; acute disseminated encephalomyelitis; CNS; central nervous system; CSF; cerebrospinal fluid; D2R; dopamine-2 receptor; DRE; drug resistant epilepsy; EEG; electroencephalogram; HSE; Herpes sim
Keywords: prostatic neoplasms; biological markers; sensitivity and specificity; prostate-specific antigen; risk; AS; active surveillance; BCR; biochemical recurrence; CAPRA-S; Cancer of the Prostate Risk Assessment Postsurgical; CCP; cell cycle progression; DRE; di
Keywords: AHR; aryl hydrocarbon receptor; AP-1; activator protein 1; ARNT; AHR nuclear translocator; BAD; Bcl-2-associated death promoter; CYP; cytochrome P450; DRE; dioxin-responsive element; ERK; extracellular signal-regulated kinase; FICZ; 6-formylindolo (3,2-b)
Keywords: RAGE; receptor for advanced glycation end product; AD; Alzheimer's disease; Aβ; amyloid β-protein; TLE; temporal lobe epilepsy; MHC; major histocompatibility; EEG; electroencephalography; MRI; magnetic resonance imaging; DRE; drug-resistant epilepsy;
Keywords: DCBI; dismounted complex blast injury; DRE; digital rectal exam; GU; genitourinary; HO; heterotopic ossification; IFI; invasive fungal infection; REBOA; resuscitative endovascular balloon occlusion of the aorta; VCA; vascularized composite allotransplanta
Keywords: AhR; aryl hydrocarbon receptor; AhR-KO; AhR-deficient mouse; AhRÎK5; keratinocyte-specific AhR-deficient; AhRÎLC; Langerhans cell-specific AhR-deficient; ALD; AhR-ligand-free synthetic diet plus indole-3-carbinol; DRE; dioxin responsive elements; FICZ
Keywords: FGFs; fibroblast growth factors; WGD; whole genome duplication; JTT; Jones-Taylor-Thornton; SPR level 5; Subtree-Pruning-Regrafting - Extensive; TM; transmembrane domain; LCR; low complexity region; TS; teleost-specific; FHF; FGF homologous factor
Keywords: DFCW; defect-free care for women; EQM; Epilepsy Quality Measures; AAN; American Academy of Neurology; AED; antiepileptic drug; DRE; drug-resistant epilepsy; Epilepsy Quality Measures; Epilepsy outcomes; Safety counseling; Women's counseling; Health-care r
Keywords: AhR; aryl hydrocarbon receptor; BAL; bronchoalveolar lavage fluid; COPD; chronic obstructory pulmonary disease; DRE; dioxin responsive element; FcÉRI; high affinity receptor for IgE; FICZ; 6-formylindolo[3,2-b]carbazole; MC; mast cell; Mast cells; Aryl h
Keywords: Co-processing; Cement kiln; DDTs/HCHs-contaminated soil; DRE;
Keywords: AUC; area under the ROC curve; BIC; Bayesian information criterion; DRE; digital rectal exam; EMR; electronic medical record; HLS; Hosmer-Lemeshow test statistic; MCMC; Markov Chain Monte Carlo; PBCG; prostate biopsy collaborative group; PCPT; prostate
Keywords: AAN; American Academy of Neurology; EQM; epilepsy quality measures; SC; seizure control; DRE; drug resistant epilepsy; DFC; Defect Free Care; PHS; Partners Healthcare System; RPDR; Research Patient Data Registry; ASD; anti seizure drug; PI; Principal Inve
Keywords: prostate; prostatic neoplasms; magnetic resonance imaging; diagnostic imaging; biopsy; ADC; apparent diffusion coefficient; ASAP; atypical small acinar proliferation; CSR; cancer suspicious region; DCE; dynamic contrast enhancement; DRE; digital rectal ex
Keywords: Prostate; Cancer; Palpation; Elastic modulus; DRE
Keywords: prostate; biopsy; pathology; laboratories; conflict of interest; DRE; digital rectal examination; ISL; independent service laboratory; PSA; prostate specific antigen; UOL; urologist owned pathology laboratory;
Keywords: AUC, area under the curve; BMI, body mass index; ROC, receiver operating characteristic; RTW, resected tissue weight; PV, prostate volumePSA; TURP; Prostate volume; Resected tissue weight; DRE
Keywords: prostate; prostatic neoplasms; biopsy; physician's practice patterns; Michigan; DRE; digital rectal examination; MUSIC; Michigan Urological Surgery Improvement Collaborative; PCa; prostate cancer; PSA; prostate specific antigen; TRUS; transrectal ultrasou
Keywords: prostatic neoplasms; robotics; prostatectomy; magnetic resonance imaging; DCEI; dynamic contrast enhanced imaging; DRE; digital rectal examination; ECE; extracapsular extension; ERC; endorectal coil; MR; magnetic resonance; MRI; magnetic resonance imaging
Keywords: AhR; aryl hydrocarbon receptor; ARE; antioxidant response element; BT; black tea; CYP; cytochrome P450; DME; drug-metabolizing enzymes; DR4; direct repeat with 4Â bp spacer; DRE; dioxin response elements; GT; green tea beverage; EC; epicatechin; EGC; epig
Keywords: AR; autosomal recessive; PDRE; pediatric drug-resistant epilepsy; DRE; drug-resistant epilepsy; EE; epileptic encephalopathy; WES; whole exome sequencing; VUS; variant of unknown significance; AED; antiepileptic drug; IGE; idiopathic generalized epilepsy;
Keywords: AUC; area under curve; CIs; confidence intervals; DOR; diagnostic odds ratio; DRE; digital rectal examination; FDA; food and drug administration; fPSA; freePSA; HSROC; hierarchical summary receiver-operator curves; PCa; prostate cancer; PHI; prostate heal